The epilepsy treatment is now approved as an add-on therapy for patients aged ≥ 2 years, following an appeal against NICE’s initial rejection.
Johnson & Johnson announced data from the Phase 3 ASTRO study of TREMFYA subcutaneous, SC, induction therapy in adults with moderately to ...
Researchers randomized patients with advanced neuroendocrine tumors 2:1 to receive either cabozantinib or placebo.
Over the past nine years, patients with spinal muscular atrophy have seen the number of FDA-approved treatment options for ...
Last week we saw the launch of the Kia Syros, the commencement of deliveries of the Skoda Kylaq, and ...
The FDA has granted priority review to brensocatib to treat patients with non-cystic fibrosis bronchiectasis, according to a ...
The Vivacity-MG3 study is currently in its open-label extension phase, which is investigating the longer-term safety and efficacy of nipocalimab for myasthenia gravis.
The arrival of the MG Cyberster marks a significant moment in ... Despite this, the Cyberster has a 0-62mph time of 3.2 seconds, which isn’t far off what a 911 Turbo Cabrio can achieve.
A Controlled Study of the Effect of Prednisone on Air-Flow Obstruction in Severe Pulmonary Emphysema
After the pretreatment week patients in Group 1 received prednisone, 60 mg. on the first and 45 mg ... complicated type of analysis. In Group 1, 3 out of 5 patients said that they felt better ...
The manufacturer doesn’t report how often side effects occurred with a dose of 3 milligrams (mg). It does note that digestive side effects tend to be more common when first starting treatment ...
Sweet, tangy grapefruit is the youngest sibling in the citrus family. Did you know it’s a cross between a pomelo and a sweet orange? While people have been cultivating lemons, limes and oranges ...
The standard dose for adults ranges between 1 and 10 mg. Some healthcare professionals ... Healthy children under age 3 years should avoid melatonin supplements unless otherwise directed by ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results